The efficacy and safety of beta-receptor blocker for infantile hemangiomas treatment:a systematic review and meta-analysis
Feng_xian WEI,Yu_ke YAN,Zhen_gang WEI,Wu Di,Qian Ni,You_cheng ZHANG
DOI: https://doi.org/10.3969/j.issn.1673-5501.2014.06.004
2014-01-01
Abstract:Objective To systematically evaluate the effectiveness and safety of beta-receptor blocker(β-R ) for infantile hemangiomas treatment. Methods Online databases of Cochrane library,PubMed,EMBASE,Web of Science Chinese biomedical literature database( CBM ),CNKI and VIP were comprehensively searched for relevant randomized controlled trials( RCTs ). Quality assessment was conducted by 6 items proposed by Cochrance handbook and data were analyzed by using RevMan 5. 3 software. Results A total of 17 RCTs with 1 097 patients were included( treatment group:585 cases,control group:512 cases). Meta-analysis result showed that propranolol was better than prednisone(OR=6. 15,95%CI:1. 69 _22. 40),worse than laser (OR=0. 13,95%CI:0. 02_0. 67),while had no significant difference with timolol(OR=0. 64,95%CI:0. 31_1. 35). The efficacy of timolol did not differ from propranolo(OR=1. 80,95%CI:0. 14_23. 37,P=0. 65)and higher than that in no treatment (OR=21. 80,95%CI:7. 10 _66. 90,P <0. 05). β-R also had advantages in aspects of onset time,tumor shape and color changing time. For safety,β-R did not cause additional complications of thyroid,liver and kidney,in which propranolol had less complications than prednisone(OR=0. 20,95%CI:0. 06~0. 65),while more complications than timolol(OR=5. 74,95%CI:2. 30 _ 14. 36 ). Heart rate, hepatic function and renal function were not obviously influenced during β-R therapy. Conclusion β-R significantly improved clinical treatment outcomes for infantile hemangiomas, and without serious adverse events. Among different kinds of drugs,timolol had an advantage of administration mode,meanwhile to some extent decreased the rate of complications,while this finding needed to be supported by further studies.